0001213900-22-077730.txt : 20221206 0001213900-22-077730.hdr.sgml : 20221206 20221205192532 ACCESSION NUMBER: 0001213900-22-077730 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221206 DATE AS OF CHANGE: 20221205 EFFECTIVENESS DATE: 20221206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466617 FILM NUMBER: 221446327 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 D 1 primary_doc.xml X0708 D LIVE 0001728328 InMed Pharmaceuticals Inc. 815 W. HASTINGS STREET SUITE 310 VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 1B4 (604) 669-7207 BRITISH COLUMBIA, CANADA None None Corporation true Eric A. Adams 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Director Sarah Li 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Alexandra D.J. Mancini 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Michael Woudenberg 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer William J. Garner 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Janet Grove 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Andrew Hull 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Bryan Baldasare 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Nicole Lemerond 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Director Eric C. Hsu 815 W. Hastings Street Suite 310 Vancouver A1 BRITISH COLUMBIA, CANADA V6C 1B4 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2022-11-21 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 All States false 6000177 6000177 0 Consists of (i) $6,000,010.50 received and (ii) approximately $166.82 to be received upon exercise of pre-funded warrants sold in the offering to purchase up to an aggregate of 1,668,185 common shares at an exercise price of $0.0001 per share. false 2 450000 0 In addition to the $450,000, the issuer paid to the sole placement agent in the offering, a management fee of $60,000, $20,000 for non-accountable expenses and $35,000 for fees and expenses of legal counsel and other out-of-pocket expenses. 0 false InMed Pharmaceuticals Inc. /s/ Eric A. Adams Eric A. Adams President and Chief Executive Officer 2022-12-01